SARS-CoV-2 Omicron lineage XBB
Selected indexed studies
- Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion. (Nat Commun, 2024) [PMID:38480689]
- SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition. (Mol Cell, 2024) [PMID:39059371]
- SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition. (bioRxiv, 2024) [PMID:38405707]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion. (2024) pubmed
- SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition. (2024) pubmed
- SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition. (2024) pubmed
- Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1. (2025) pubmed
- Neutralization of SARS-CoV-2 Omicron XBB.1.5 and JN.1 variants after COVID-19 booster-vaccination and infection. (2024) pubmed
- Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread. (2023) pubmed
- SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors. (2023) pubmed
- A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants. (2025) pubmed
- XBB.1.5: A new threatening SARS-CoV-2 Omicron subvariant. (2023) pubmed
- SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry. (2024) pubmed